<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.3-a.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//news-medic.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://news-medic.com/2026/09/21/terapia-arn-esperanza-para-enfermedades-raras-de-neurona-motora/</loc>
  <lastmod>2026-09-21T06:05:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>news medic</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Terapia ARN: Esperanza para Enfermedades Raras de Neurona Motora</news:title>
   <news:publication_date>2026-09-21T06:05:19Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://news-medic.com/2026/09/20/teclistamab-el-fin-de-los-marcadores-de-cancer-en-pacientes-de-alto-riesgo/</loc>
  <lastmod>2026-09-20T06:04:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>news medic</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Teclistamab: ¿El fin de los marcadores de cáncer en pacientes de alto riesgo?</news:title>
   <news:publication_date>2026-09-20T06:04:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://news-medic.com/2026/09/20/crispr-desvela-gen-clave-en-resistencia-a-farmacos-contra-cancer-de-sangre/</loc>
  <lastmod>2026-09-20T06:03:58Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>news medic</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>CRISPR desvela gen clave en resistencia a fármacos contra cáncer de sangre</news:title>
   <news:publication_date>2026-09-20T06:03:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://news-medic.com/2026/09/19/b-cells-la-clave-para-predecir-la-colitis-por-inmunoterapia/</loc>
  <lastmod>2026-09-19T06:05:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>news medic</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>B cells: ¿La clave para predecir la colitis por inmunoterapia?</news:title>
   <news:publication_date>2026-09-19T06:05:19Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://news-medic.com/2026/09/19/mesotelioma-nueva-droga-usa-las-defensas-del-cancer-en-su-contra/</loc>
  <lastmod>2026-09-19T06:05:03Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>news medic</news:name>
    <news:language>es</news:language>
   </news:publication>
   <news:title>Mesotelioma: Nueva droga usa las defensas del cáncer en su contra</news:title>
   <news:publication_date>2026-09-19T06:05:03Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
